|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34,350 KRW | +0.29% |
|
+1.78% | -10.55% |
On January 24, 2024, GenEdit Inc. closed the transaction. The company received $24,000,000 total gross proceeds in the transaction. The transaction included participation from new investor F. Hoffmann-La Roche AG.
The company signed a partnership with Genentech. The company received $22,300,000 in its second and final tranche closing.
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 67,500 KRW | -2.17% | -2.32% | 427M | ||
| 34,350 KRW | +0.29% | +1.78% | 296M | ||
| 1st Jan change | Capi. | |
|---|---|---|
| -10.55% | 296M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
HUONS CO., LTD. 
